Literature DB >> 23428810

Involvement of serotonin receptor mechanisms in the discriminative stimulus effects of ketamine in rats.

Kazumi Yoshizawa1, Tomohisa Mori, Tamami Ueno, Mizuki Nishiwaki, Masahiro Shibasaki, Norifumi Shimizu, Minoru Narita, Tsutomu Suzuki.   

Abstract

We have demonstrated previously that the ketamine-induced discriminative stimulus effect is likely to reflect the phencyclidine-like psychotomimetic effects. Therefore, the present study was designed to investigate the effects of the antipsychotics and 5-HT2 receptor antagonist on the discriminative stimulus effects of ketamine in rats. While sulpiride did not attenuate the discriminative stimulus effects of ketamine, both clozapine and ketanserin attenuated those of ketamine, suggesting that the discriminative stimulus effects of ketamine are mediated by multiple receptors, especially the 5-HT2 receptor, but not the D2 receptor. Furthermore, our findings imply that atypical antipsychotics could be useful for the treatment of psychotomimetic effects induced by ketamine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428810     DOI: 10.1254/jphs.12148sc

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  4 in total

1.  GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.

Authors:  Rong-Jian Liu; Catharine Duman; Taro Kato; Brendan Hare; Dora Lopresto; Eunyoung Bang; Jeffery Burgdorf; Joseph Moskal; Jane Taylor; George Aghajanian; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2016-09-16       Impact factor: 7.853

2.  Subanalgesic ketamine enhances morphine-induced antinociceptive activity without cortical dysfunction in rats.

Authors:  Hiroki Shikanai; Sachiko Hiraide; Hidekazu Kamiyama; Tsukasa Kiya; Koji Oda; Yoshikazu Goto; Yoshiki Yanagawa; Kei-ichi Shimamura; Yukiko Goda; Hiroko Togashi
Journal:  J Anesth       Date:  2013-10-11       Impact factor: 2.078

3.  Downregulation of the NLRP3/Caspse-1 Pathway Ameliorates Ketamine-Induced Liver Injury and Inflammation in Developing Rats.

Authors:  Xinzhang Chen; Zhiheng Zhang; Meilun Shen; Xiangying Ma; Di Qiu; Siyao Li; Li Gao
Journal:  Molecules       Date:  2022-05-04       Impact factor: 4.927

4.  The monoaminergic pathways and inhibition of monoamine transporters interfere with the antidepressive-like behavior of ketamine.

Authors:  Glauce Socorro de Barros Viana; Cecilia Coelho Xavier; Eduardo Mulato do Vale; Maria Janice Pereira Lopes; Viviane de Jesus Alves; Roberta de Oliveira Costa; Kelly Rose Tavares Neves
Journal:  IBRO Rep       Date:  2017-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.